Patents by Inventor M. Olson

M. Olson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10251990
    Abstract: A method for automated processing of a cellular product comprising target substrate cells, the method comprising providing a separation apparatus configured to associate with a disposable sterile circuit comprising a separator in communication with the cellular product.
    Type: Grant
    Filed: April 27, 2017
    Date of Patent: April 9, 2019
    Assignee: Fenwal, Inc.
    Inventors: Christopher J. Wegener, Bret M. Olson, Alaina Schlinker, Steven Binninger, Avnie A. Kadakia
  • Publication number: 20190092768
    Abstract: The present application provides bifunctional compounds of Formula (I): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which act as protein degradation inducing moieties for cyclin-dependent kinase 4 (CDK4) and/or cyclin-dependent kinase 6 (CDK6). The present application also relates to methods for the targeted degradation of CDK4 and/or CDK6 through the use of the bifunctional compounds that link a ubiquitin ligase-binding moiety to a ligand that is capable of binding to CDK4 and/or CDK6 which can be utilized in the treatment of disorders modulated by CDK4 and/or CDK6.
    Type: Application
    Filed: April 21, 2017
    Publication date: March 28, 2019
    Inventors: Nathanael S. GRAY, Tinghu ZHANG, Calla M. OLSON, Yanke LIANG, Nicholas KWIATKOWSKI
  • Patent number: 10241581
    Abstract: This document describes techniques for radio frequency (RF) based micro-motion tracking. These techniques enable even millimeter-scale hand motions to be tracked. To do so, radar signals are used from radar systems that, with conventional techniques, would only permit resolutions of a centimeter or more.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: March 26, 2019
    Assignees: Google LLC, The Board of Trustees of the Lealand Stanford Junior University
    Inventors: Jaime Lien, Erik M. Olson, Patrick M. Amihood, Ivan Poupyrev
  • Patent number: 10229020
    Abstract: A rework re-timer with forward error correction handling is disclosed. An example first intermediate transceiver includes a first interface to communicatively couple the first intermediate transceiver with a first computing device, a second interface to communicatively couple the first intermediate transceiver to a second intermediate transceiver configured to be communicatively coupled with a second computing device, an auto-negotiation controller to: terminate a first auto-negotiation with the first computing device before the first auto-negotiation is completed, transmit, to the second transceiver, first capabilities of the first computing device determined during the first auto-negotiation, and perform a second auto-negotiation with the first computing device utilizing the first capabilities of the first computing device and second capabilities of the second computing device received from the second transceiver.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: March 12, 2019
    Assignee: Hewlett Packard Enterprise Development LP
    Inventors: David M. Olson, John Wastlick, Jason Jung, Kevin B. Leigh
  • Publication number: 20190038732
    Abstract: Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
    Type: Application
    Filed: October 19, 2018
    Publication date: February 7, 2019
    Inventors: Douglas G. McNeel, Brian M. Olson
  • Publication number: 20190029772
    Abstract: Tissue localization devices and methods of localizing tissue using tissue localization devices are disclosed. The tissue localization device can comprise a handle comprising a delivery control, a delivery needle extending out from the handle, and a localization element within the delivery needle. The localization element can be deployed out of the delivery needle or retracted back into the delivery needle when the delivery control is translated in a first direction or a second direction, respectively. The localization element can be coupled to a flexible tracking wire.
    Type: Application
    Filed: September 28, 2018
    Publication date: January 31, 2019
    Applicant: Focal Therapeutics Inc.
    Inventors: George D. HERMANN, Jonathan M. OLSON, Michael J. DREWS, Gail S. LEBOVIC, David B. WILLIS
  • Publication number: 20190029773
    Abstract: Tissue localization devices and methods of localizing tissue using tissue localization devices are disclosed. The tissue localization device can comprise a handle comprising a delivery control, a delivery needle extending out from the handle, and a localization element within the delivery needle. The localization element can be deployed out of the delivery needle or retracted back into the delivery needle when the delivery control is translated in a first direction or a second direction, respectively. The localization element can be coupled to a flexible tracking wire.
    Type: Application
    Filed: September 28, 2018
    Publication date: January 31, 2019
    Applicant: Focal Therapeutics Inc.
    Inventors: George D. HERMANN, Jonathan M. OLSON, Michael J. DREWS, Gail S. LEBOVIC, David B. WILLIS
  • Publication number: 20190021812
    Abstract: Tissue localization devices and methods of localizing tissue using tissue localization devices are disclosed. The tissue localization device can comprise a handle comprising a delivery control, a delivery needle extending out from the handle, and a localization element within the delivery needle. The localization element can be deployed out of the delivery needle or retracted back into the delivery needle when the delivery control is translated in a first direction or a second direction, respectively. The localization element can be coupled to a flexible tracking wire.
    Type: Application
    Filed: September 26, 2018
    Publication date: January 24, 2019
    Applicant: Focal Therapeutics Inc.
    Inventors: George D. HERMANN, Jonathan M. OLSON, Michael J. DREWS, Gail S. LEBOVIC, David B. WILLIS
  • Publication number: 20190015631
    Abstract: An infusion catheter assembly has the ability to infinitely titrate the length of a porous fluid distribution section in situ. The infusion catheter assembly thereby provides a length of infusion that can be infinitely varied over a prescribed range, to control the effective infusion length and the rate of infusion. Using the infusion catheter assembly, a physician has the capability to treat only the length of the vessel desired, thereby preventing excessive drug/patient exposures. The porous fluid distribution section can include an array of spaced apart apertures that vary in size and/or density along the length of the porous fluid distribution section, such that the flow rate remains essentially constant for a given inlet pressure independent of the effective infusion length.
    Type: Application
    Filed: July 25, 2018
    Publication date: January 17, 2019
    Inventors: Anthony J. Comerota, Thomas J. Fogarty, Jonathan M. Olson, Richard A. Lotti
  • Publication number: 20180347049
    Abstract: Methods for forming sintered-bonded high temperature coatings over ceramic turbomachine components are provided, as are ceramic turbomachine components having such high temperature coatings formed thereover. In one embodiment, the method includes the step or process of removing a surface oxide layer from the ceramic component body of a turbomachine component to expose a treated surface of the ceramic component body. A first layer of coating precursor material, which has a solids content composed predominately of at least one rare earth silicate by weight percentage, is applied to the treated surface. The first layer of the coating precursor material is then heat treated to sinter the solids content and form a first sintered coating layer bonded to the treated surface. The steps of applying and sintering the coating precursor may be repeated, as desired, to build a sintered coating body to a desired thickness over the ceramic component body.
    Type: Application
    Filed: May 30, 2017
    Publication date: December 6, 2018
    Applicant: HONEYWELL INTERNATIONAL INC.
    Inventors: Reza Oboodi, James Piascik, Donald M. Olson, Natalie Kruk, Terence Whalen
  • Publication number: 20180348339
    Abstract: Techniques and apparatuses are described that enable radar modulations for radar sensing using a wireless communication chipset. A controller initializes or controls modulations performed by the wireless communication chipset. In this way, the controller can enable the wireless communication chipset to perform modulations for wireless communication or radar sensing. In some cases, the controller can further select a wireless communication channel for setting a frequency and a bandwidth of a radar signal, thereby avoiding interference between multiple radar signals or between the radar signal and a communication signal. In other cases, the controller can cause the wireless communication chipset to modulate a signal containing communication data using a radar modulation. This enables another device that receives the signal to perform wireless communication or radar sensing. By utilizing these techniques, the wireless communication chipset can be used for wireless communication or radar sensing.
    Type: Application
    Filed: March 22, 2018
    Publication date: December 6, 2018
    Applicant: Google LLC
    Inventors: Jaime Lien, Changzhan Gu, Erik M. Olson
  • Patent number: 10143194
    Abstract: An elevatable platform system for mounting on a vehicle having an elevatable platform elevatable by a collapsible support structure. The support structure is adapted to move the elevatable platform between a lowered position in which the elevatable platform is positioned at a height proximate to or below the height of the vehicle and an elevated position in which the elevatable platform is elevated above the vehicle. Support legs integrated into the support structure can be deployed from the support structure when the elevatable platform is elevated to further stabilize the elevated platform.
    Type: Grant
    Filed: February 17, 2011
    Date of Patent: December 4, 2018
    Assignee: Traveling Tower LLC
    Inventors: Todd A. Rubey, Jeffry M. Olson
  • Publication number: 20180335138
    Abstract: An apparatus for ratio control of a continuously variable transmission includes a driver commanded ratio unit outputting a signal defining a commanded ratio. A clamp control portion is in communication with the driver commanded ratio unit. The clamp control portion includes: a ratio limits and override ring selecting a ratio matching the commanded ratio from an executable functions having stored ratio code data; a screening monitor continuously receiving output from the executable functions and using an input from a vehicle speed signal to compute minimum and maximum ratio limits for the ratio selected by the ratio limits and override ring; and a ratio control execution ring in communication with the screening monitor. The ratio control execution ring calculates a range of pressures allowed for operation of both primary and secondary pulleys of the continuously variable transmission.
    Type: Application
    Filed: May 16, 2017
    Publication date: November 22, 2018
    Inventors: Ronald F. Lochocki, Christopher J. Weingartz, Greg J. Perantoni, Stuart W. Parker, Paul G. Otanez, Bret M. Olson, Mary M. Whitley, Nathan A. Schmidt
  • Patent number: 10111940
    Abstract: Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
    Type: Grant
    Filed: August 16, 2016
    Date of Patent: October 30, 2018
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Douglas G. McNeel, Brian M. Olson
  • Publication number: 20180272078
    Abstract: A fluid delivery device includes an array of needles, each in fluid communication with a respective reservoir. Respective actuators are coupled so as to be operable to drive fluid from the reservoirs via needle ports. Each needle can have a plurality, of ports, and the ports can be arranged to deliver a substantially equal amount of fluid at any given location along its length. A driver is coupled to the actuators to selectively control the rate, volume, and direction of flow of fluid through the needles. The device can simultaneously deliver a plurality of fluid agents along respective axes in solid tissue in vivo. If thereafter resected, the tissue can be sectioned for evaluation of an effect of each agent on the tissue, and based on the evaluation, candidate agents selected or deselected for clinical trials or therapy, and subjects selected or deselected for clinical trials or therapeutic treatment.
    Type: Application
    Filed: October 11, 2017
    Publication date: September 27, 2018
    Inventors: S. Bahram Bahrami, Mandana Veiseh, James M. Olson
  • Patent number: 10082215
    Abstract: A fluid circuit includes a device, a cooler, and a valve. The valve includes a housing, a sealing member, a biasing device, and an actuator. The sealing member moves inside the housing between a first position and a second position. The actuator includes a smart material that is activated when the temperature of a fluid inside the housing exhibiting at least a first temperature, causing the sealing member to move to the second position. The smart material is deactivated when the fluid is a sufficient number of degrees less than the first temperature, causing the sealing member to move to the first position. The fluid flows from the housing to the device and then to the housing when the sealing member is in the first position. The fluid flows from the housing to the cooler and then to the device when the sealing member is in the second position.
    Type: Grant
    Filed: August 31, 2016
    Date of Patent: September 25, 2018
    Assignees: GM Global Technology Operations LLC, Dynalloy, Inc.
    Inventors: Xiujie Gao, Nancy L. Johnson, Bret M. Olson, Vijay A. Neelakantan, Tyler P. Ownby, James H. Brown
  • Patent number: 10058679
    Abstract: An infusion catheter assembly has the ability to infinitely titrate the length of a porous fluid distribution section in situ. The infusion catheter assembly thereby provides a length of infusion that can be infinitely varied over a prescribed range, to control the effective infusion length and the rate of infusion. Using the infusion catheter assembly, a physician has the capability to treat only the length of the vessel desired, thereby preventing excessive drug/patient exposures. The porous fluid distribution section can include an array of spaced apart apertures that vary in size and/or density along the length of the porous fluid distribution section, such that the flow rate remains essentially constant for a given inlet pressure independent of the effective infusion length.
    Type: Grant
    Filed: April 12, 2016
    Date of Patent: August 28, 2018
    Assignee: Venous Therapy Inc.
    Inventors: Anthony J. Comerota, Thomas J. Fogarty, Jonathan M. Olson, Richard A. Lotti
  • Patent number: 10047860
    Abstract: A target module determines a target ratio between a speed of an input shaft and a speed of an output shaft of a continuously variable transmission (CVT) based on an accelerator pedal position. A maximum rate of change (ROC) module determines a maximum ROC of the target ratio. A switching valve control module, based on a comparison of the maximum ROC and a ROC of the target ratio, selectively actuates a switching valve of the CVT one of (i) from a closed position to an open position and (ii) from the open position to the closed position. The switching valve prevents transmission fluid flow through a flow path between a transmission fluid pump and a pressure regulator valve of the CVT when the switching valve is in the closed position. The switching valve allows transmission fluid flow through the flow path when the switching valve is in the open position.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: August 14, 2018
    Assignee: GM GLOBAL TECHNOLOGY OPERATIONS LLC
    Inventors: Minh Q. Truong, Bret M. Olson, Chinar S. Ghike, Craig J. Hawkins, Steven P. Moorman, Paul G. Otanez
  • Publication number: 20180193897
    Abstract: A hose fitting swaging device may include a base at least two truss rods, first and second die collars and a hydraulic cylinder. The truss rods may be spaced apart from each other and extend upward from the base. Each truss rod may have a proximal end removably secured to the base. Each truss rod may also have a distal end opposite the base. The first die collar may be removably secured to the distal ends of the truss rods. The second die collar may be slideably retained by the truss rods, between the base and the first die collar. The hydraulic cylinder may be removably secured to the base in between the truss rods and beneath the second die collar. Thus, the hydraulic cylinder may be operable to forcibly drive the second die collar upwards, along the truss rods, toward the first die collar. The first die collar may be supported entirely by the truss rods.
    Type: Application
    Filed: January 12, 2017
    Publication date: July 12, 2018
    Inventors: Richard D. Dresang, Daniel M. Olson, Bernard M. Hengels, Kevin J. Witt, Jack V. Roberts, Charles S. Duginski, Brian Robert Blake, Dean Robert Rohn, Robert H. Glick, Chad P. Brunink
  • Publication number: 20180194818
    Abstract: Chlorotoxin variants, chlorotoxin variant conjugates, compositions that include the chlorotoxin variants or conjugates, and methods for using the chlorotoxin variants, conjugates, and compositions.
    Type: Application
    Filed: March 2, 2018
    Publication date: July 12, 2018
    Inventor: James M. OLSON